4th Annual Cleaning Validation 2024 - A Practical Approach

For pharma, maintaining stringent cleaning standards is non-negotiable. The stakes are high, and the margin for error is slim. Cross-contamination can compromise product quality, endanger patient safety, and lead to costly regulatory penalties.

Illumina Acquires Fluent BioSciences To Advance Single cell Analysis

Illumina, a US based biotechnology firm, declared that it has acquired Fluent BioSciences, developer of an emerging and highly differentiated single-cell technology. Fluent's single-cell examination innovation takes out the requirement for...

Alembic Pharma Receives USFDA Nod for Bromfenac ophthalmic solution

Alembic Pharmaceuticals Ltd said that the US Food and Drug Administration has granted final approval for its generic Bromfenac ophthalmic solution, which is recommended for the treatment of postoperative inflammation and pain in patients who have...

60 Degrees Pharma Declares IRB Approval of Clinical Study

60 Degrees Pharmaceuticals, Inc, a leading firm focused on growing new medicines for infectious ailments, reported morals endorsement of an open label, extended access study of the ARAKODA® routine of tafenoquine in blend with standard of care...

EddingPharm Secures China NMPA Approval for Vascepa

Amarin Corporation plc, an innovative pharmaceutical firm, stated that its commercial partner in Mainland China (China), EddingPharm (Edding), has gained regulatory approval for Vascepa (icosapent ethyl) from the National Medical Products...

Abbott Drives Vertigo Understanding With 'Chakkar Ko Check Kar' campaign

Abbott, the global healthcare leader, launched its ‘Chakkar Ko Check Kar’ campaign in India to highlightanoften-overlooked balance disorder,vertigo, which affects close to 70 million people in India.Vertigo is a condition that can make people feel...

© 2024 India Pharma Outlook. All Rights Reserved.